|LETTER TO EDITOR
|Year : 2019 | Volume
| Issue : 4 | Page : 331
Reply-letter to editor: From compression to injections: prostaglandins paving a new direction for venous leg ulcer treatment
Rajendra Prasad Basavanthappa, Ashwini Naveen Gangadharan, Sanjay C Desai, AR Chandrashekar
Departments of Vascular and Endovascular Surgery, Ramaiah Medical College, Bengaluru, Karnataka, India
|Date of Submission||29-Nov-2019|
|Date of Decision||29-Nov-2019|
|Date of Acceptance||29-Nov-2019|
|Date of Web Publication||20-Dec-2019|
Rajendra Prasad Basavanthappa
Departments of Vascular and Endovascular Surgery, Ramaiah Medical College, Bengaluru, Karnataka
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Basavanthappa RP, Gangadharan AN, Desai SC, Chandrashekar A R. Reply-letter to editor: From compression to injections: prostaglandins paving a new direction for venous leg ulcer treatment. Indian J Vasc Endovasc Surg 2019;6:331
|How to cite this URL:|
Basavanthappa RP, Gangadharan AN, Desai SC, Chandrashekar A R. Reply-letter to editor: From compression to injections: prostaglandins paving a new direction for venous leg ulcer treatment. Indian J Vasc Endovasc Surg [serial online] 2019 [cited 2020 Jan 22];6:331. Available from: http://www.indjvascsurg.org/text.asp?2019/6/4/331/273585
Thank you for the wonderful feedback and pointing out the issues.
First with regard to the cost of prostaglandin. At our center, prostaglandin costs around Rs. 4800–5200. Considering the early healing of the ulcer resulting in decreased hospital trips and the number of dressings, the overall cost may even out. But for confirmation, we have to analyze the same which was not done in our study as it was a pilot study. We shall try to include the same in the future.
Second, regarding the potential for major side effects of prostaglandins. All the patients in the study were thoroughly counseled and the high risks were explained. During the prostaglandin infusion, vitals were monitored hourly and any side effects were identified and corrected immediately. As we were not comfortable performing a retrograde venous perfusion, the same was not attempted.
Finally, with regard to the Split thickness skin grafts (SSG). We have a considerable load of venous ulcer patients in our center and the vascular surgery team and plastic surgery team have not noted good results with SSG in these patients. The factors, which we noted, were usually due to cost and compliance. Hence, these days we do not prefer SSGs in venous ulcers.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.